Qing Re Liang Xue Decoction Alleviates Hypercoagulability in Kawasaki Disease

Table 1

Clinical characteristics of KD patients, febrile patients, and healthy children.

	IG ()	WG ()	Febrile group ()	Healthy group ()
Male/female	22/9	25/3	24/6	22/6
Age onset (years)
<1 year	8	8	2	3
1–5 years	23	19	24	21
>5 years	0	1	4	4

Note: IG: integrative medicine treatment group (treated with Qing Re Liang Xue decoction and Western medicine); WG: Western medicine treatment group (treated with IVIG and/or aspirin); febrile group: children who had a fever with pneumonia or bronchitis; healthy group: healthy children without any diseases; KD: Kawasaki disease.